{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T19:02:41Z","timestamp":1787166161258,"version":"build-2736575974"},"reference-count":82,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","license":[{"start":{"date-parts":[[2024,10,23]],"date-time":"2024-10-23T00:00:00Z","timestamp":1729641600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,6]]},"abstract":"<jats:p>Postoperative acute kidney injury after liver transplant (LT) has long-term implications for kidney health. LT recipients are at risk of acute kidney injury due to a number of factors related to the donor liver, intraoperative factors including surgical technique, as well as recipient factors, such as pre-LT kidney function and postoperative complications. This review discusses these factors in detail and their impact on posttransplant kidney function. Long-term risk factors such as calcineurin inhibitors have also been discussed. Additionally, the impact of liver allocation policies on pre- and post-LT kidney health is discussed.<\/jats:p>","DOI":"10.1097\/tp.0000000000005252","type":"journal-article","created":{"date-parts":[[2024,10,23]],"date-time":"2024-10-23T00:00:42Z","timestamp":1729641642000},"page":"938-944","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":7,"title":["Optimization and Protection of Kidney Health in Liver Transplant Recipients: Intra- and Postoperative Approaches"],"prefix":"10.1097","volume":"109","author":[{"given":"Muhammad Y.","family":"Jan","sequence":"first","affiliation":[{"name":"Division of Transplant Nephrology, Department of Medicine, Indiana University School of Medicine, Indianapolis, IN."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kavish R.","family":"Patidar","sequence":"additional","affiliation":[{"name":"Section of Gastroenterology and Hepatology, Department of Medicine, Baylor College of Medicine and Michael E. DeBakey Veterans Affairs Medical Center, Houston, TX."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marwan S.","family":"Ghabril","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology, Department of Medicine, Indiana University School of Medicine, Indianapolis, IN."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chandrashekhar A.","family":"Kubal","sequence":"additional","affiliation":[{"name":"Division of Transplant Surgery, Department of Surgery, Indiana University School of Medicine, Indianapolis, IN."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,10,23]]},"reference":[{"key":"R1-20250714","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1002\/lt.26417","article-title":"Intraoperative risk factors of acute kidney injury after liver transplantation.","volume":"28","author":"Berkowitz","year":"2022","journal-title":"Liver Transpl"},{"key":"R2-20250714","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1093\/bja\/aeu556","article-title":"Acute kidney injury following orthotopic liver transplantation: incidence, risk factors, and effects on patient and graft outcomes.","volume":"114","author":"Hilmi","year":"2015","journal-title":"Br J Anaesth"},{"key":"R3-20250714","doi-asserted-by":"crossref","first-page":"372","DOI":"10.3390\/jcm8030372","article-title":"Incidence and impact of acute kidney injury after liver transplantation: a meta-analysis.","volume":"8","author":"Thongprayoon","year":"2019","journal-title":"J Clin Med"},{"key":"R4-20250714","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1097\/TP.0000000000002305","article-title":"Acute kidney injury after liver transplantation.","volume":"102","author":"Durand","year":"2018","journal-title":"Transplantation"},{"key":"R5-20250714","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1097\/TP.0000000000004851","article-title":"Optimization of kidney health in liver transplant candidates: pretransplant considerations and modalities.","volume":"108","author":"Jan","year":"2024","journal-title":"Transplantation"},{"key":"R6-20250714","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1053\/j.jvca.2016.12.002","article-title":"Relationship between intraoperative hypotension and acute kidney injury after living donor liver transplantation: a retrospective analysis.","volume":"31","author":"Mizota","year":"2017","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"R7-20250714","doi-asserted-by":"crossref","first-page":"e308","DOI":"10.1097\/TP.0000000000003331","article-title":"The association between vena cava implantation technique and acute kidney injury after liver transplantation.","volume":"104","author":"Hannon","year":"2020","journal-title":"Transplantation"},{"key":"R8-20250714","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1186\/s12882-021-02360-8","article-title":"Modifiable risk factors of acute kidney injury after liver transplantation: a systematic review and meta-analysis.","volume":"22","author":"Zhou","year":"2021","journal-title":"BMC Nephrol"},{"key":"R9-20250714","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1080\/00365521.2022.2028004","article-title":"Perioperative kidney injury in liver transplantation: a prospective study with renal histology and measured glomerular filtration rates.","volume":"57","author":"Nor\u00e9n","year":"2022","journal-title":"Scand J Gastroenterol"},{"key":"R10-20250714","first-page":"CD009052","article-title":"Methods to decrease blood loss and transfusion requirements for liver transplantation.","volume":"2011","author":"Gurusamy","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"key":"R11-20250714","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/s13054-017-1675-4","article-title":"Renal function and oxygenation are impaired early after liver transplantation despite hyperdynamic systemic circulation.","volume":"21","author":"Skytte Larsson","year":"2017","journal-title":"Crit Care"},{"key":"R12-20250714","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s12871-020-01228-y","article-title":"Intraoperative hypotension during liver transplant surgery is associated with postoperative acute kidney injury: a historical cohort study.","volume":"21","author":"Joosten","year":"2021","journal-title":"BMC Anesthesiol"},{"key":"R13-20250714","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1002\/lt.25334","article-title":"Piggyback or cava replacement: which implantation technique protects liver recipients from acute kidney injury and complications?","volume":"24","author":"Widmer","year":"2018","journal-title":"Liver Transpl"},{"key":"R14-20250714","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1213\/ANE.0000000000002311","article-title":"Venovenous bypass is associated with a lower incidence of acute kidney injury after liver transplantation in patients with compromised pretransplant renal function.","volume":"125","author":"Sun","year":"2017","journal-title":"Anesth Analg"},{"key":"R15-20250714","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1002\/hep.510230618","article-title":"Effect of venovenous bypass on perioperative renal function in liver transplantation: results of a randomized, controlled trial.","volume":"23","author":"Grande","year":"1996","journal-title":"Hepatology"},{"key":"R16-20250714","doi-asserted-by":"crossref","first-page":"e14681","DOI":"10.1111\/ctr.14681","article-title":"Which cava anastomotic techniques are optimal regarding immediate and short-term outcomes after liver transplantation: a systematic review of the literature and expert panel recommendations.","volume":"36","author":"Shaker","year":"2022","journal-title":"Clin Transplant"},{"key":"R17-20250714","doi-asserted-by":"crossref","first-page":"539","DOI":"10.6002\/ect.2021.0050","article-title":"Not all piggybacks are equal: a retrospective cohort analysis of variation in anhepatic transcaval pressure gradient and acute kidney injury during liver transplant.","volume":"19","author":"Oliver","year":"2021","journal-title":"Exp Clin Transplant"},{"key":"R18-20250714","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1053\/jlts.2001.27870","article-title":"Temporary portocaval shunt during liver transplantation with vena cava preservation. Results of a prospective randomized study.","volume":"7","author":"Figueras","year":"2001","journal-title":"Liver Transpl"},{"key":"R19-20250714","doi-asserted-by":"crossref","first-page":"82","DOI":"10.5152\/tjg.2020.19592","article-title":"Risk factors for the incidence and severity of acute kidney injury after liver transplantation.","volume":"32","author":"Zhang","year":"2021","journal-title":"Turk J Gastroenterol"},{"key":"R20-20250714","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.clinre.2018.07.009","article-title":"Early acute kidney injury after liver transplantation in patients with normal preoperative renal function.","volume":"43","author":"Tan","year":"2019","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"R21-20250714","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/S1665-2681(19)30763-X","article-title":"Risk factors for acute kidney injury and 30-day mortality after liver transplantation.","volume":"14","author":"Barreto","year":"2015","journal-title":"Ann Hepatol"},{"key":"R22-20250714","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1097\/TP.0000000000002085","article-title":"The impact of combined warm ischemia time on development of acute kidney injury in donation after circulatory death liver transplantation: stay within the golden hour.","volume":"102","author":"Kalisvaart","year":"2018","journal-title":"Transplantation"},{"key":"R23-20250714","doi-asserted-by":"crossref","first-page":"9337","DOI":"10.1038\/s41598-019-45843-3","article-title":"Hypothermic oxygenated machine perfusion of liver grafts from brain-dead donors.","volume":"9","author":"Patrono","year":"2019","journal-title":"Sci Rep"},{"key":"R24-20250714","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1097\/SLA.0000000000005110","article-title":"Hypothermic oxygenated machine perfusion reduces early allograft injury and improves post-transplant outcomes in extended criteria donation liver transplantation from donation after brain death: results from a multicenter randomized controlled trial (HOPE ECD-DBD).","volume":"274","author":"Czigany","year":"2021","journal-title":"Ann Surg"},{"key":"R25-20250714","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1001\/jamasurg.2021.6781","article-title":"Impact of portable normothermic blood-based machine perfusion on outcomes of liver transplant: the OCS Liver PROTECT Randomized Clinical Trial.","volume":"157","author":"Markmann","year":"2022","journal-title":"JAMA Surgery"},{"key":"R26-20250714","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/s41586-018-0047-9","article-title":"A randomized trial of normothermic preservation in liver transplantation.","volume":"557","author":"Nasralla","year":"2018","journal-title":"Nature"},{"key":"R27-20250714","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1002\/lt.25755","article-title":"Renal dysfunction after liver transplantation: effect of donor type.","volume":"26","author":"Kollmann","year":"2020","journal-title":"Liver Transpl"},{"key":"R28-20250714","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1111\/ajt.15877","article-title":"Perioperative and long-term outcomes of utilizing donation after circulatory death liver grafts with macrosteatosis: a multicenter analysis.","volume":"20","author":"Croome","year":"2020","journal-title":"Am J Transplant"},{"key":"R29-20250714","doi-asserted-by":"crossref","first-page":"e13019","DOI":"10.1111\/ctr.13019","article-title":"Impact of terlipressin infusion during and after live donor liver transplantation on incidence of acute kidney injury and neutrophil gelatinase-associated lipocalin serum levels: a randomized controlled trial.","volume":"31","author":"Kandil","year":"2017","journal-title":"Clin Transplant"},{"key":"R30-20250714","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1002\/lt.24759","article-title":"Double-blind randomized controlled trial of the routine perioperative use of terlipressin in adult living donor liver transplantation.","volume":"23","author":"Reddy","year":"2017","journal-title":"Liver Transpl"},{"key":"R31-20250714","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1002\/lt.20145","article-title":"Use of fenoldopam to control renal dysfunction early after liver transplantation.","volume":"10","author":"Biancofiore","year":"2004","journal-title":"Liver Transpl"},{"key":"R32-20250714","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1213\/01.ANE.0000136420.01393.81","article-title":"Fenoldopam mesylate and renal function in patients undergoing liver transplantation: a randomized, controlled pilot trial.","volume":"99","author":"Rocca","year":"2004","journal-title":"Anesth Analg"},{"key":"R33-20250714","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1111\/j.1440-1746.2009.05873.x","article-title":"Effects of terlipressin on systemic, hepatic and renal hemodynamics in patients with cirrhosis.","volume":"24","author":"Narahara","year":"2009","journal-title":"J Gastroenterol Hepatol"},{"key":"R34-20250714","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.jceh.2021.06.019","article-title":"Prophylactic perioperative terlipressin therapy for preventing acute kidney injury in living donor liver transplant recipients: a systematic review and meta-analysis.","volume":"12","author":"Kulkarni","year":"2022","journal-title":"J Clin Exp Hepatol"},{"key":"R35-20250714","doi-asserted-by":"crossref","first-page":"101899","DOI":"10.1016\/j.clinre.2022.101899","article-title":"Restrictive intraoperative fluid intake in liver surgery and postoperative renal function: a propensity score matched study.","volume":"46","author":"Eyraud","year":"2022","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"R36-20250714","doi-asserted-by":"crossref","first-page":"e14651","DOI":"10.1111\/ctr.14651","article-title":"Perioperative fluid management and outcomes in adult deceased donor liver transplantation\u2014a systematic review of the literature and expert panel recommendations.","volume":"36","author":"Morkane","year":"2022","journal-title":"Clin Transplant"},{"key":"R37-20250714","article-title":"Simultaneous Liver Kidney (SLK) Allocation Policy Webpage: Policy Document."},{"key":"R38-20250714","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1097\/TP.0000000000002908","article-title":"Delayed graft function in simultaneous liver kidney transplantation.","volume":"104","author":"Weeks","year":"2020","journal-title":"Transplantation"},{"key":"R39-20250714","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1016\/j.surg.2021.05.012","article-title":"Combined liver-kidney transplantation with positive crossmatch: role of delayed kidney transplantation.","volume":"170","author":"Goggins","year":"2021","journal-title":"Surgery"},{"key":"R40-20250714","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1002\/lt.26232","article-title":"Temporal trends and evolving outcomes after simultaneous liver-kidney transplantation: results from the US SLKT Consortium.","volume":"27","author":"Cullaro","year":"2021","journal-title":"Liver Transpl"},{"key":"R41-20250714","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1111\/ajt.13631","article-title":"Simultaneous liver-kidney allocation policy: a proposal to optimize appropriate utilization of scarce resources.","volume":"16","author":"Formica","year":"2016","journal-title":"Am J Transplant"},{"key":"R42-20250714","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1056\/NEJM199410273311702","article-title":"A comparison of tacrolimus (FK 506) and cyclosporine for immunosuppression in liver transplantation.","volume":"331","year":"1994","journal-title":"N Engl J Med"},{"key":"R43-20250714","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1111\/ajt.13171","article-title":"Improved survival in liver transplant recipients receiving prolonged-release tacrolimus in the European Liver Transplant Registry.","volume":"15","author":"Adam","year":"2015","journal-title":"Am J Transplant"},{"key":"R44-20250714","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1016\/j.jhep.2010.12.001","article-title":"Immunosuppression in liver transplant recipients with renal impairment.","volume":"54","author":"Duvoux","year":"2011","journal-title":"J Hepatol"},{"key":"R45-20250714","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0272-6386(89)80032-0","article-title":"Renal vascular and thrombotic effects of cyclosporine.","volume":"13","author":"Remuzzi","year":"1989","journal-title":"Am J Kidney Dis"},{"key":"R46-20250714","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1111\/j.1600-6143.2011.03841.x","article-title":"Thrombotic microangiopathy after living-donor liver transplantation.","volume":"12","author":"Shindoh","year":"2012","journal-title":"Am J Transplant"},{"key":"R47-20250714","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.blre.2014.09.001","article-title":"De novo thrombotic microangiopathy after non-renal solid organ transplantation.","volume":"28","author":"Verbiest","year":"2014","journal-title":"Blood Rev"},{"key":"R48-20250714","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1016\/j.dld.2021.12.006","article-title":"Renal function after liver transplantation: real-world experience with basiliximab induction and delayed reduced-dose tacrolimus.","volume":"54","author":"Cederborg","year":"2022","journal-title":"Dig Liver Dis"},{"key":"R49-20250714","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1111\/j.1600-6143.2008.02493.x","article-title":"Delayed introduction of reduced-dose tacrolimus, and renal function in liver transplantation: the \u2018ReSpECT\u2019 study.","volume":"9","author":"Neuberger","year":"2009","journal-title":"Am J Transplant"},{"key":"R50-20250714","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1002\/lt.20490","article-title":"Evaluation of renal function in liver transplant recipients receiving daclizumab (Zenapax), mycophenolate mofetil, and a delayed, low-dose tacrolimus regimen vs. a standard-dose tacrolimus and mycophenolate mofetil regimen: a multicenter randomized clinical trial.","volume":"11","author":"Yoshida","year":"2005","journal-title":"Liver Transpl"},{"key":"R51-20250714","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1111\/j.1600-6143.2012.04049.x","article-title":"A randomized, controlled study to assess the conversion from calcineurin-inhibitors to everolimus after liver transplantation\u2014PROTECT.","volume":"12","author":"Fischer","year":"2012","journal-title":"Am J Transplant"},{"key":"R52-20250714","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1111\/j.1600-6143.2011.03919.x","article-title":"Sirolimus conversion regimen versus continued calcineurin inhibitors in liver allograft recipients: a randomized trial.","volume":"12","author":"Abdelmalek","year":"2012","journal-title":"Am J Transplant"},{"key":"R53-20250714","doi-asserted-by":"crossref","first-page":"3008","DOI":"10.1111\/j.1600-6143.2012.04212.x","article-title":"Everolimus with reduced tacrolimus improves renal function in de novo liver transplant recipients: a randomized controlled trial.","volume":"12","author":"De Simone","year":"2012","journal-title":"Am J Transplant"},{"key":"R54-20250714","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1111\/ajt.12280","article-title":"Renal function at two years in liver transplant patients receiving everolimus: results of a randomized, multicenter study.","volume":"13","author":"Saliba","year":"2013","journal-title":"Am J Transplant"},{"key":"R55-20250714","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1097\/TP.0000000000000555","article-title":"Three-year outcomes in de novo liver transplant patients receiving everolimus with reduced tacrolimus: follow-up results from a randomized, multicenter study.","volume":"99","author":"Fischer","year":"2015","journal-title":"Transplantation"},{"key":"R56-20250714","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1002\/lt.23658","article-title":"Calcineurin inhibitor-free mycophenolate mofetil\/sirolimus maintenance in liver transplantation: the randomized spare-the-nephron trial.","volume":"19","author":"Teperman","year":"2013","journal-title":"Liver Transpl"},{"key":"R57-20250714","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1111\/ajt.14212","article-title":"Efficacy and safety of everolimus and mycophenolic acid with early tacrolimus withdrawal after liver transplantation: a multicenter randomized trial.","volume":"17","author":"Saliba","year":"2017","journal-title":"Am J Transplant"},{"key":"R58-20250714","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1111\/ajt.14623","article-title":"Efficacy and safety of everolimus with reduced tacrolimus in living-donor liver transplant recipients: 12-month results of a randomized multicenter study.","volume":"18","author":"Jeng","year":"2018","journal-title":"Am J Transplant"},{"key":"R59-20250714","doi-asserted-by":"crossref","first-page":"e13415","DOI":"10.1111\/ctr.13415","article-title":"Delayed calcineurin inhibitor introduction and renal outcomes in liver transplant recipients receiving basiliximab induction.","volume":"32","author":"Lange","year":"2018","journal-title":"Clin Transplant"},{"key":"R60-20250714","doi-asserted-by":"crossref","first-page":"e480","DOI":"10.1097\/TXD.0000000000000917","article-title":"Renal outcomes of liver transplantation recipients receiving standard immunosuppression and early renal sparing Immunosuppression: a retrospective single center study.","volume":"5","author":"Sharma","year":"2019","journal-title":"Transplant Direct"},{"key":"R61-20250714","doi-asserted-by":"crossref","first-page":"e24387","DOI":"10.1371\/journal.pone.0024387","article-title":"Calcineurin-inhibitor minimization in liver transplant patients with calcineurin-inhibitor-related renal dysfunction: a meta-analysis.","volume":"6","author":"Kong","year":"2011","journal-title":"PLoS One"},{"key":"R62-20250714","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1002\/lt.25400","article-title":"Very early introduction of everolimus in de novo liver transplantation: results of a multicenter, prospective, randomized trial.","volume":"25","author":"Cillo","year":"2019","journal-title":"Liver Transpl"},{"key":"R63-20250714","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.transproceed.2020.09.021","article-title":"Long-term outcomes of everolimus therapy in de novo liver transplantation: a systematic review and meta-analysis of randomized controlled trials.","volume":"53","author":"Bzeizi","year":"2021","journal-title":"Transplant Proc"},{"key":"R64-20250714","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1111\/ajt.12810","article-title":"Belatacept-based immunosuppression in de novo liver transplant recipients: 1-year experience from a phase II randomized study.","volume":"14","author":"Klintmalm","year":"2014","journal-title":"Am J Transplant"},{"key":"R65-20250714","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1002\/lt.21827","article-title":"Conversion from a calcineurin inhibitor to everolimus therapy in maintenance liver transplant recipients: a prospective, randomized, multicenter trial.","volume":"15","author":"De Simone","year":"2009","journal-title":"Liver Transpl"},{"key":"R66-20250714","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1002\/lt.22292","article-title":"Conversion to everolimus in maintenance liver transplant patients: a multicenter, retrospective analysis.","volume":"17","author":"Saliba","year":"2011","journal-title":"Liver Transpl"},{"key":"R67-20250714","doi-asserted-by":"crossref","first-page":"2567","DOI":"10.1016\/j.transproceed.2009.06.152","article-title":"Combined mycophenolate mofetil and minimal dose calcineurin inhibitor therapy in liver transplant patients: clinical results of a prospective randomized study.","volume":"41","author":"Beckebaum","year":"2009","journal-title":"Transplant Proc"},{"key":"R68-20250714","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1002\/lt.20903","article-title":"Mycophenolate mofetil in combination with reduction of calcineurin inhibitors for chronic renal dysfunction after liver transplantation.","volume":"12","author":"Pageaux","year":"2006","journal-title":"Liver Transpl"},{"key":"R69-20250714","doi-asserted-by":"crossref","first-page":"2601","DOI":"10.1111\/j.1600-6143.2012.04157.x","article-title":"Calcineurin inhibitor sparing with mycophenolate mofetil in liver transplantion: a systematic review of randomized controlled trials.","volume":"12","author":"Goralczyk","year":"2012","journal-title":"Am J Transplant"},{"key":"R70-20250714","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0960-0760(98)00099-5","article-title":"Androgen-induced vitellogenin gene expression in primary cultures of rainbow trout hepatocytes.","volume":"67","author":"Mori","year":"1998","journal-title":"J Steroid Biochem Mol Biol"},{"key":"R71-20250714","doi-asserted-by":"crossref","first-page":"52","DOI":"10.4174\/astr.2020.99.1.52","article-title":"Perioperative risk factors of progressive chronic kidney disease following liver transplantation: analyses of a 10-year follow-up single-center cohort.","volume":"99","author":"Lee","year":"2020","journal-title":"Ann Surg Treat Res"},{"key":"R72-20250714","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1056\/NEJMoa021744","article-title":"Chronic renal failure after transplantation of a nonrenal organ.","volume":"349","author":"Ojo","year":"2003","journal-title":"N Engl J Med"},{"key":"R73-20250714","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1053\/j.ajkd.2014.01.416","article-title":"KDOQI US commentary on the 2012 KDIGO clinical practice guideline for the evaluation and management of CKD.","volume":"63","author":"Inker","year":"2014","journal-title":"Am J Kidney Dis"},{"key":"R74-20250714","doi-asserted-by":"crossref","first-page":"3593","DOI":"10.1111\/ajt.16761","article-title":"Developing simultaneous liver-kidney transplant medical eligibility criteria while providing a safety net: a 2-year review of the OPTN\u2019s allocation policy.","volume":"21","author":"Wilk","year":"2021","journal-title":"Am J Transplant"},{"key":"R75-20250714","doi-asserted-by":"crossref","first-page":"3513","DOI":"10.1111\/ajt.16796","article-title":"Mission accomplished? Early data from the simultaneous liver-kidney transplantation allocation policy.","volume":"21","author":"Asrani","year":"2021","journal-title":"Am J Transplant"},{"key":"R76-20250714","doi-asserted-by":"crossref","first-page":"2372","DOI":"10.1111\/j.1600-6143.2011.03703.x","article-title":"Impact of MELD-based allocation on end-stage renal disease after liver transplantation.","volume":"11","author":"Sharma","year":"2011","journal-title":"Am J Transplant"},{"key":"R77-20250714","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1002\/lt.21821","article-title":"Renal outcomes after liver transplantation in the model for end-stage liver disease era.","volume":"15","author":"Sharma","year":"2009","journal-title":"Liver Transpl"},{"key":"R78-20250714","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1681\/ASN.2013040436","article-title":"Patient-specific prediction of ESRD after liver transplantation.","volume":"24","author":"Sharma","year":"2013","journal-title":"J Am Soc Nephrol"},{"key":"R79-20250714","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.transproceed.2017.11.009","article-title":"Liver transplant recipients with end-stage renal disease largely benefit from kidney transplantation.","volume":"50","author":"Yunhua","year":"2018","journal-title":"Transplant Proc"},{"key":"R80-20250714","doi-asserted-by":"crossref","first-page":"e14812","DOI":"10.1111\/ctr.14812","article-title":"Predictors of renal recovery in recipients of liver transplant alone who met 2017 simultaneous liver-kidney transplant criteria.","volume":"36","author":"Cui","year":"2022","journal-title":"Clin Transplant"},{"key":"R81-20250714","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.hbpd.2021.02.001","article-title":"Application of machine learning models for predicting acute kidney injury following donation after cardiac death liver transplantation.","volume":"20","author":"He","year":"2021","journal-title":"Hepatobiliary Pancreat Dis Int"},{"key":"R82-20250714","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1186\/s12967-021-02990-4","article-title":"An explainable supervised machine learning predictor of acute kidney injury after adult deceased donor liver transplantation.","volume":"19","author":"Zhang","year":"2021","journal-title":"J Translat Med"}],"container-title":["Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/TP.0000000000005252","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,14]],"date-time":"2025-07-14T19:00:33Z","timestamp":1752519633000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/TP.0000000000005252"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,23]]},"references-count":82,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/tp.0000000000005252","relation":{},"ISSN":["0041-1337","1534-6080"],"issn-type":[{"value":"0041-1337","type":"print"},{"value":"1534-6080","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,23]]}}}